Author Question: Which of the statements about price discrimination is (are) false? a. It must be possible to ... (Read 37 times)

ARLKQ

  • Hero Member
  • *****
  • Posts: 571
Which of the statements about price discrimination is (are) false?
 a. It must be possible to segment the market.
  b. It must be difficult to transfer the seller's product from one market segment to another.
  c. Public utilities practice first-degree price discrimination.
  d. There must be differences in the elasticity of demand from one segment to another.
  e. c and d

Question 2

Which of the following will improve your supplier contracting bargaining position
 a. Your supplier merges with an alternative supplier
  b. You redesign your component requirements to be more flexible across different potential suppliers
  c. You redesign your component requirements so that your preferred supplier is more integral to product success
  d. Your supplier's chief competitor has exited the market



sokh

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

c

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library